Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 27, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 12.5 mg.".
Ann. Date
2026-03-27 15:19:28
Dissemination
27-Mar-2026 15:19:30
Attachment
📄 Download PDF
APLLTD_27032026151905_Intimation_to_SE_Press_Release_FA_signed.pdf
Created
2026-03-27T09:51:02.246Z
Updated
2026-03-27T09:51:02.440Z
AI Analysis
Pending analysis.
The analyzer worker will process this record on its next run.